These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 34070212)
1. The Glitazone Class of Drugs as Carbonic Anhydrase Inhibitors-A Spin-Off Discovery from Fragment Screening. Mueller SL; Chrysanthopoulos PK; Halili MA; Hepburn C; Nebl T; Supuran CT; Nocentini A; Peat TS; Poulsen SA Molecules; 2021 May; 26(10):. PubMed ID: 34070212 [TBL] [Abstract][Full Text] [Related]
2. Identification of a New Zinc Binding Chemotype by Fragment Screening. Chrysanthopoulos PK; Mujumdar P; Woods LA; Dolezal O; Ren B; Peat TS; Poulsen SA J Med Chem; 2017 Sep; 60(17):7333-7349. PubMed ID: 28817930 [TBL] [Abstract][Full Text] [Related]
3. Recent advances in the discovery of zinc-binding motifs for the development of carbonic anhydrase inhibitors. Winum JY; Supuran CT J Enzyme Inhib Med Chem; 2015 Apr; 30(2):321-4. PubMed ID: 24939097 [TBL] [Abstract][Full Text] [Related]
4. Non-zinc mediated inhibition of carbonic anhydrases: coumarins are a new class of suicide inhibitors. Maresca A; Temperini C; Vu H; Pham NB; Poulsen SA; Scozzafava A; Quinn RJ; Supuran CT J Am Chem Soc; 2009 Mar; 131(8):3057-62. PubMed ID: 19206230 [TBL] [Abstract][Full Text] [Related]
5. Dithiocarbamates: a new class of carbonic anhydrase inhibitors. Crystallographic and kinetic investigations. Carta F; Aggarwal M; Maresca A; Scozzafava A; McKenna R; Supuran CT Chem Commun (Camb); 2012 Feb; 48(13):1868-70. PubMed ID: 22218610 [TBL] [Abstract][Full Text] [Related]
7. S-glycosyl primary sulfonamides--a new structural class for selective inhibition of cancer-associated carbonic anhydrases. Lopez M; Paul B; Hofmann A; Morizzi J; Wu QK; Charman SA; Innocenti A; Vullo D; Supuran CT; Poulsen SA J Med Chem; 2009 Oct; 52(20):6421-32. PubMed ID: 19827837 [TBL] [Abstract][Full Text] [Related]
8. Dissecting the inhibition mechanism of cytosolic versus transmembrane carbonic anhydrases by ESR. Ciani L; Cecchi A; Temperini C; Supuran CT; Ristori S J Phys Chem B; 2009 Oct; 113(42):13998-4005. PubMed ID: 19778001 [TBL] [Abstract][Full Text] [Related]
9. Design of a carbonic anhydrase IX active-site mimic to screen inhibitors for possible anticancer properties. Genis C; Sippel KH; Case N; Cao W; Avvaru BS; Tartaglia LJ; Govindasamy L; Tu C; Agbandje-McKenna M; Silverman DN; Rosser CJ; McKenna R Biochemistry; 2009 Feb; 48(6):1322-31. PubMed ID: 19170619 [TBL] [Abstract][Full Text] [Related]
10. Structural insights into carbonic anhydrase IX isoform specificity of carbohydrate-based sulfamates. Moeker J; Mahon BP; Bornaghi LF; Vullo D; Supuran CT; McKenna R; Poulsen SA J Med Chem; 2014 Oct; 57(20):8635-45. PubMed ID: 25254302 [TBL] [Abstract][Full Text] [Related]
11. Structural study of interaction between brinzolamide and dorzolamide inhibition of human carbonic anhydrases. Pinard MA; Boone CD; Rife BD; Supuran CT; McKenna R Bioorg Med Chem; 2013 Nov; 21(22):7210-5. PubMed ID: 24090602 [TBL] [Abstract][Full Text] [Related]
12. Native State Mass Spectrometry, Surface Plasmon Resonance, and X-ray Crystallography Correlate Strongly as a Fragment Screening Combination. Woods LA; Dolezal O; Ren B; Ryan JH; Peat TS; Poulsen SA J Med Chem; 2016 Mar; 59(5):2192-204. PubMed ID: 26882437 [TBL] [Abstract][Full Text] [Related]
13. Advances in the structural annotation of human carbonic anhydrases and impact on future drug discovery. Nocentini A; Supuran CT Expert Opin Drug Discov; 2019 Nov; 14(11):1175-1197. PubMed ID: 31436118 [No Abstract] [Full Text] [Related]
14. Carbonic anhydrase inhibitors. Inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, IX, and XII with Schiff's bases incorporating chromone and aromatic sulfonamide moieties, and their zinc complexes. Puccetti L; Fasolis G; Vullo D; Chohan ZH; Scozzafava A; Supuran CT Bioorg Med Chem Lett; 2005 Jun; 15(12):3096-101. PubMed ID: 15908204 [TBL] [Abstract][Full Text] [Related]
15. Kinetic and X-ray crystallographic investigations of substituted 2-thio-6-oxo-1,6-dihydropyrimidine-benzenesulfonamides acting as carbonic anhydrase inhibitors. Vullo D; Supuran CT; Scozzafava A; De Simone G; Monti SM; Alterio V; Carta F Bioorg Med Chem; 2016 Aug; 24(16):3643-8. PubMed ID: 27316543 [TBL] [Abstract][Full Text] [Related]
16. Carbonic anhydrase inhibitors: X-ray crystal structure of a benzenesulfonamide strong CA II and CA IX inhibitor bearing a pentafluorophenylaminothioureido tail in complex with isozyme II. Di Fiore A; De Simone G; Menchise V; Pedone C; Casini A; Scozzafava A; Supuran CT Bioorg Med Chem Lett; 2005 Apr; 15(7):1937-42. PubMed ID: 15780637 [TBL] [Abstract][Full Text] [Related]
17. Combining the tail and the ring approaches for obtaining potent and isoform-selective carbonic anhydrase inhibitors: solution and X-ray crystallographic studies. Bozdag M; Ferraroni M; Nuti E; Vullo D; Rossello A; Carta F; Scozzafava A; Supuran CT Bioorg Med Chem; 2014 Jan; 22(1):334-40. PubMed ID: 24300919 [TBL] [Abstract][Full Text] [Related]
18. Hydroxamate represents a versatile zinc binding group for the development of new carbonic anhydrase inhibitors. Di Fiore A; Maresca A; Supuran CT; De Simone G Chem Commun (Camb); 2012 Sep; 48(70):8838-40. PubMed ID: 22836518 [TBL] [Abstract][Full Text] [Related]
19. Identification of 3,4-Dihydroisoquinoline-2(1H)-sulfonamides as potent carbonic anhydrase inhibitors: synthesis, biological evaluation, and enzyme--ligand X-ray studies. Gitto R; Agnello S; Ferro S; De Luca L; Vullo D; Brynda J; Mader P; Supuran CT; Chimirri A J Med Chem; 2010 Mar; 53(6):2401-8. PubMed ID: 20170095 [TBL] [Abstract][Full Text] [Related]
20. Saccharin: a lead compound for structure-based drug design of carbonic anhydrase IX inhibitors. Mahon BP; Hendon AM; Driscoll JM; Rankin GM; Poulsen SA; Supuran CT; McKenna R Bioorg Med Chem; 2015 Feb; 23(4):849-54. PubMed ID: 25614109 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]